Terms: = Pancreatic cancer AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1 AND Prognosis
33 results:
1. vhl suppresses autophagy and tumor growth through PHD1-dependent Beclin1 hydroxylation.
Wang Z; Yan M; Ye L; Zhou Q; Duan Y; Jiang H; Wang L; Ouyang Y; Zhang H; Shen Y; Ji G; Chen X; Tian Q; Xiao L; Wu Q; Meng Y; Liu G; Ma L; Lei B; Lu Z; Xu D
EMBO J; 2024 Mar; 43(6):931-955. PubMed ID: 38360997
[TBL] [Abstract] [Full Text] [Related]
2. [Multiple neuroendocrine tumors of the pancreas].
Sipos B
Pathologie (Heidelb); 2024 Feb; 45(1):28-34. PubMed ID: 38180510
[TBL] [Abstract] [Full Text] [Related]
3. Genotype-phenotype correlations and clinical outcomes of patients with von Hippel-Lindau disease with large deletions.
Zhang K; Yang W; Ma K; Qiu J; Li L; Xu Y; Zhang Z; Yu C; Zhou J; Gong Y; Cai L; Gong K
J Med Genet; 2023 May; 60(5):477-483. PubMed ID: 37080588
[TBL] [Abstract] [Full Text] [Related]
4. Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade.
Terry S; Dalban C; Rioux-Leclercq N; Adam J; Meylan M; Buart S; Bougoüin A; Lespagnol A; Dugay F; Moreno IC; Lacroix G; Lorens JB; Gausdal G; Fridman WH; Mami-Chouaib F; Chaput N; Beuselinck B; Chabaud S; Barros-Monteiro J; Vano Y; Escudier B; Sautès-Fridman C; Albiges L; Chouaib S
Clin Cancer Res; 2021 Dec; 27(24):6749-6760. PubMed ID: 34407968
[TBL] [Abstract] [Full Text] [Related]
5. Clinical presentation, genotype-phenotype correlations, and outcome of pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome.
Penitenti F; Landoni L; Scardoni M; Piredda ML; Cingarlini S; Scarpa A; D'Onofrio M; Girelli D; Davi MV
Endocrine; 2021 Oct; 74(1):180-187. PubMed ID: 34036514
[TBL] [Abstract] [Full Text] [Related]
6. Genotype-phenotype correlation in von Hippel-Lindau disease.
Reich M; Jaegle S; Neumann-Haefelin E; Klingler JH; Evers C; Daniel M; Bucher F; Ludwig F; Nuessle S; Kopp J; Boehringer D; Reinhard T; Lagrèze WA; Lange C; Agostini H; Lang SJ
Acta Ophthalmol; 2021 Dec; 99(8):e1492-e1500. PubMed ID: 33720516
[TBL] [Abstract] [Full Text] [Related]
7. Diagnostic and management strategies for pNETs in Von Hippel-Lindau: a systematic review.
Ahmad S; Naber MR; Giles RH; Valk GD; van Leeuwaarde RS
Endocr Relat Cancer; 2021 Mar; 28(3):151-160. PubMed ID: 33512331
[TBL] [Abstract] [Full Text] [Related]
8. Integration of transcriptome and cistrome analysis identifies RUNX1-target genes involved in pancreatic cancer proliferation.
Liu S; Xie F; Gan L; Peng T; Xu X; Guo S; Fu W; Wang Y; Ouyang Y; Yang J; Wang X; Zheng Y; Zhang J; Wang H
Genomics; 2020 Nov; 112(6):5343-5355. PubMed ID: 33189780
[TBL] [Abstract] [Full Text] [Related]
9. Novel genetic characterisation and phenotype correlation in von Hippel-Lindau (vhl) disease based on the Elongin C binding site: a large retrospective study.
Xie H; Ma K; Zhang J; Hong B; Zhou J; Li L; Zhang K; Gong K; Cai L
J Med Genet; 2020 Nov; 57(11):744-751. PubMed ID: 32303605
[TBL] [Abstract] [Full Text] [Related]
10. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
Couvelard A; Scoazec JY
Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
[TBL] [Abstract] [Full Text] [Related]
11. Imaging Diagnosis of Von Hippel-Lindau Syndrome.
Xu N; Duan W; Zhang R; Yang B
J Craniofac Surg; 2019 Oct; 30(7):e674-e677. PubMed ID: 31574790
[TBL] [Abstract] [Full Text] [Related]
12. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours.
Scarpa A
Ann Endocrinol (Paris); 2019 Jun; 80(3):153-158. PubMed ID: 31072588
[TBL] [Abstract] [Full Text] [Related]
13. [Diagnosis and treatment of pancreatic neuroendocrine neoplasmas in Von Hippel-Lindau syndrome].
Liu WK; Tian XD; Yang YM
Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):869-872. PubMed ID: 30392308
[TBL] [Abstract] [Full Text] [Related]
14. In silico vhl Gene Mutation Analysis and prognosis of pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease.
Tirosh A; El Lakis M; Green P; Nockel P; Patel D; Nilubol N; Gara SK; Keutgen XM; Linehan WM; Kebebew E
J Clin Endocrinol Metab; 2018 Apr; 103(4):1631-1638. PubMed ID: 29294023
[TBL] [Abstract] [Full Text] [Related]
15. Association of vhl Genotype With pancreatic Neuroendocrine Tumor Phenotype in Patients With von Hippel-Lindau Disease.
Tirosh A; Sadowski SM; Linehan WM; Libutti SK; Patel D; Nilubol N; Kebebew E
JAMA Oncol; 2018 Jan; 4(1):124-126. PubMed ID: 29075773
[TBL] [Abstract] [Full Text] [Related]
16. 18F-FDG Uptake in Well-Differentiated Neuroendocrine Tumors Correlates with Both Ki-67 and vhl Pathway Inactivation.
Bucau M; Laurent-Bellue A; Poté N; Hentic O; Cros J; Mikail N; Rebours V; Ruszniewski P; Lebtahi R; Couvelard A
Neuroendocrinology; 2018; 106(3):274-282. PubMed ID: 28803235
[TBL] [Abstract] [Full Text] [Related]
17. [Von Hippel-Lindau syndrome - two sides of the same coin].
Páleníková P; Adamcová M; Šturdík I; Ftáčniková B; Copáková L; Payer J
Vnitr Lek; 2016; 62(12):1004-1008. PubMed ID: 28139130
[TBL] [Abstract] [Full Text] [Related]
18.
Satoh K; Sadowski SM; Dieckmann W; Quezado M; Nilubol N; Kebebew E; Patel D
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):714-721. PubMed ID: 27638678
[TBL] [Abstract] [Full Text] [Related]
19. Somatic and germline mutations in NETs: Implications for their diagnosis and management.
Minnetti M; Grossman A
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):115-27. PubMed ID: 26971848
[TBL] [Abstract] [Full Text] [Related]
20. Endocrine manifestations of von Hippel-Lindau disease.
Cassol C; Mete O
Arch Pathol Lab Med; 2015 Feb; 139(2):263-8. PubMed ID: 25611110
[TBL] [Abstract] [Full Text] [Related]
[Next]